A Phase 3 interventional study of 33525 and Placebo in Tinea Pedis, sponsored by Medicis Global Service Corporation. Completed at 11 sites in 2 countries. Open to participants aged 12 Years and older. Per ClinicalTrials.gov, last updated 2013-08-28.
Sponsored by Medicis Global Service Corporation (part of Bausch Health Companies Inc.) · Phase 3, Interventional, and Treatment
The purpose of this study is to determine if a topical antifungal cream is safe and effective for the treatment of tinea pedis.
73 studies on the registry are indexed under Tinea Pedis; 8 are open to participants now.
This study's enrollment of 322 is above the median of 128 across 66 interventional studies indexed under Tinea Pedis.
Browse Tinea Pedis studies →Medicis Global Service Corporation is the lead sponsor of 12 studies on the registry; none are open to participants now.
First submitted before Medicis Global Service Corporation became part of Bausch Health Companies Inc..
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Product 33525
Drug: 33525
Product 33525 Placebo
Drug: Placebo
Daily for 14 days
Daily for 14 days
Proportion of patients achieving complete clearance
Signs and Symptoms Severity Score and negative Potassium Hydroxide (KOH) and Culture
Time frame: Day 42
Proportion of patients achieving effective treatment
Clinical Cure and Mycologic Cure
Time frame: Day 42
This study is completed, as verified in Aug 2013. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Medicis Global Service Corporation →